NCT00988260View on ClinicalTrials.gov

Japanese Bridging Trial of Org 37462 (Study P05969)(COMPLETED)

PHASE2CompletedINTERVENTIONAL
Enrollment

266

Participants

Timeline

Start Date

February 3, 2003

Primary Completion Date

April 12, 2004

Study Completion Date

April 12, 2004

Conditions
Controlled Ovarian Stimulation
Interventions
DRUG

Ganirelix

Ganirelix 0.125 mg subcutaneous daily (SC OD) for up to 14 days

DRUG

Ganirelix

Ganirelix 0.25 mg subcutaneous daily (SC OD) for up to 14 days

DRUG

Ganirelix

Ganirelix 0.5 mg subcutaneous daily (SC OD) for up to 14 days

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00988260 - Japanese Bridging Trial of Org 37462 (Study P05969)(COMPLETED) | Biotech Hunter | Biotech Hunter